Regulations.gov document
Demonstrating Substantial Evidence of Effectiveness for Human Drug and Biological…
Notice · FDA-2019-D-4964 · posted Jan 27, 2020
Key facts
| Document ID | FDA-2019-D-4964-0009 |
|---|---|
| Title | Demonstrating Substantial Evidence of Effectiveness for Human Drug and Biological Products; Draft Guidance for Industry; Availability; Extension of Comment Period |
| Document type | Notice |
| Subtype | Extension of Comment Period |
| Agency | FDA |
| Docket | FDA-2019-D-4964 |
| Posted | Jan 27, 2020 |
| Federal Register citation | 85 FR 4670 |
| FR document number | 2020-01322 |
| Comment period opens | Jan 27, 2020 |
| Effective date | Jan 27, 2020 |
At a glance
- 1–9 Pages
- 10–99 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: